Pharmafile Logo
Pharmafocus logo
Advanced Search

Amgen

Showing 15 posts of 216 posts found.

bayer_cross_2

Nexavar gains FDA ‘speed lane’ status for thyroid cancer

August 28, 2013
Research and Development, Sales and Marketing Amgen, Nexavar, Onyx

News
amgen

Amgen buys Onyx for $10.4 billion

August 27, 2013
Research and Development, Sales and Marketing Amgen, Kyprolis, Onyx

News
Amgen image

Amgen signs Servier deal

July 11, 2013
Sales and Marketing Amgen, Servier, heart, procoloran

Amgen has gained rights in the US to two of Servier’s heart drugs: the novel, oral Procoralan and investigational Phase …

News
Amgen image

Onyx rejects Amgen – seeks new suitors

July 2, 2013
Sales and Marketing Amgen, Onyx

Amgen’s advances for Onyx have been knocked back as the biotech firm says it is now seeking new suitors. Onyx …

News
Amgen image

Amgen moves into Japanese market with Astellas deal

May 29, 2013
Sales and Marketing Amgen, Astellas, Vectibix, Zhejiang

Amgen and Astellas have announced a new collaboration that will see them launch five new medicines in Japan from 2016, …

News
Amgen image

Amgen and Zhejiang sign cancer deal

May 14, 2013
Sales and Marketing Amgen, Cancer, Zhejiang

Amgen has signed a joint venture deal with Chinese firm Zhejiang Beta Pharma to commercialise oncology drug Vectibix. The companies …

News
Amgen image

Amgen earmarks $200m for new Singapore plant

January 18, 2013
Manufacturing and Production Amgen, Merck, Singapore

Amgen has unveiled plans to construct a new manufacturing plant in Singapore, its first production facility in Asia. The biotechnology …

News
amgen image

$700m fines for Amgen

December 20, 2012
Manufacturing and Production, Sales and Marketing Amgen, FDA, off label, off-label

Amgen has pleaded guilty to misbranding its anaemia drug Aranesp following a string of US lawsuits against the biotech company. The …

News
eckert

Amgen appoints Mattel’s Robert Eckert to Board of directors

December 14, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Eckert

Biotech firm Amgen has announced the appointment of Robert Eckert, former chief executive officer at Mattel, to its Board of …

Appointment

Amgen’s Roger Perlmutter joins Heptares

October 23, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Heptares, Roger Perlmutter

GPCR drug discovery firm Heptares Therapeutics has elected Dr Roger Perlmutter, the former executive VP, Research and Development, at Amgen …

Appointment
patton_cynthia_dec_5_2005

Amgen appoints senior VP and chief compliance officer

October 18, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Cynthia Patton

Amgen has announced the appointment of Cynthia Patton to senior vice president and chief compliance officer. Patton will report to …

Appointment
27

Amgen names Ray Jordan senior VP Corporate Affairs

September 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, J&J, JJ, Ray Jordan

Amgen has announced the appointment of ex-J&J comms leader Ray Jordan to the new position of senior vice president, Corporate …

Appointment
UCB image

UCB opens Belgian pilot plant

September 17, 2012
Manufacturing and Production Amgen, Belgium, R&D, UCB

UCB has officially opened a new pilot biotech plant at its Braine-L’Alleud site in Belgium.The 5,100 sq. m. facility – …

News
Xgeva image

Xgeva gains NICE recommendation for bone metastasis

August 17, 2012
Sales and Marketing Amgen, NICE, Xgeva, bone metastatis

NICE is continuing to recommend Amgen’s Xgeva for certain groups of cancer patients whose disease has spread to their bones. …

News
Amgen image

Amgen unveils plan to close Epogen plant

August 14, 2012
Manufacturing and Production Amgen, Epogen, cuts, omontys

Amgen has said it will close down a manufacturing facility in Longmont, Colorado, in the face of declining sales of …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025